These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 24004178

  • 1. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM, Crapper J, Philips G, Sharma K, Chan HK, Traini D.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
    [Abstract] [Full Text] [Related]

  • 2. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H, Young PM, Chan HK, Agus H, Traini D.
    Eur J Pharm Sci; 2010 Jun 14; 40(3):239-47. PubMed ID: 20371286
    [Abstract] [Full Text] [Related]

  • 3. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 14; 27(2):81-93. PubMed ID: 24502451
    [Abstract] [Full Text] [Related]

  • 4. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis.
    Young PM, Salama RO, Zhu B, Phillips G, Crapper J, Chan HK, Traini D.
    Drug Dev Ind Pharm; 2015 May 14; 41(5):859-65. PubMed ID: 24811055
    [Abstract] [Full Text] [Related]

  • 5. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B, Young PM, Ong HX, Crapper J, Flodin C, Qiao EL, Phillips G, Traini D.
    J Pharm Sci; 2015 Jul 14; 104(7):2169-76. PubMed ID: 25931324
    [Abstract] [Full Text] [Related]

  • 6. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N, Ahn P, Park H, Bhujbal S, Zemlyanov D, Cavallaro A, Mangal S, Li J, Zhou QT.
    Mol Pharm; 2018 Sep 04; 15(9):4004-4020. PubMed ID: 30028947
    [Abstract] [Full Text] [Related]

  • 7. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K, Katona G, Csóka I, Ambrus R.
    J Pharm Biomed Anal; 2018 Jan 30; 148():73-79. PubMed ID: 28965047
    [Abstract] [Full Text] [Related]

  • 8. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection.
    Arora S, Haghi M, Loo CY, Traini D, Young PM, Jain S.
    Mol Pharm; 2015 Jun 01; 12(6):2001-9. PubMed ID: 25923171
    [Abstract] [Full Text] [Related]

  • 9. Cospray dried antibiotics for dry powder lung delivery.
    Adi H, Young PM, Chan HK, Stewart P, Agus H, Traini D.
    J Pharm Sci; 2008 Aug 01; 97(8):3356-66. PubMed ID: 17990305
    [Abstract] [Full Text] [Related]

  • 10. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT.
    Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544
    [Abstract] [Full Text] [Related]

  • 11. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
    Parumasivam T, Leung SS, Tang P, Mauro C, Britton W, Chan HK.
    AAPS J; 2017 Jan 10; 19(1):191-202. PubMed ID: 27679516
    [Abstract] [Full Text] [Related]

  • 12. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H, Teo J, Chew JW, Hadinoto K.
    Int J Pharm; 2016 Feb 29; 499(1-2):38-46. PubMed ID: 26757148
    [Abstract] [Full Text] [Related]

  • 13. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y, Chang RYK, Britton WJ, Morales S, Kutter E, Li J, Chan HK.
    Eur J Pharm Biopharm; 2019 Sep 29; 142():543-552. PubMed ID: 31398437
    [Abstract] [Full Text] [Related]

  • 14. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
    Karimi K, Pallagi E, Szabó-Révész P, Csóka I, Ambrus R.
    Drug Des Devel Ther; 2016 Sep 29; 10():3331-3343. PubMed ID: 27784991
    [Abstract] [Full Text] [Related]

  • 15. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM.
    Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131
    [Abstract] [Full Text] [Related]

  • 16. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 15; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.